31.1 C
Vientiane
Saturday, May 10, 2025
spot_img
Home Blog Page 959

Aon names Anne Corona as CEO of Enterprise Clients and Global Chief Commercial Officer


DUBLIN, IRELAND – Media OutReach Newswire – 3 December 2024 Aon plc (NYSE: AON), a leading global professional services firm, today announces the appointment of Anne Corona as CEO of Enterprise Clients and global chief commercial officer, effective 1 January 2025.

Anne-Corona Headshot

This appointment is part of the firm’s strategy to advance its commercial capabilities by deepening commercial alignment, integration of data and analytics and service excellence globally to better service clients.

In this role, Corona will work with Aon’s Enterprise Client Group leaders and regional chief commercial officers as the firm continues to evolve its next generation Aon Client Leadership strategy to deliver integrated solutions to clients to help them protect and grow their businesses.

“The challenges our clients are facing are multi-faceted, complex and interconnected, and all require agility and the ability to make decisions quickly, said Lori Goltermann, CEO of Regions and North America for Aon. “Anne’s exceptional leadership and strategic vision will strengthen Aon’s commercial capabilities and expertise to help our clients make better decisions across risk and people issues.”

Corona brings a wealth of experience from her nearly 25-year career with Aon, most recently serving as CEO of Asia Pacific, based in Singapore. She has demonstrated exceptional leadership and strategic vision, building momentum and unity in the region, driving innovation and growth by enhancing the firm’s capability across all solution lines and fostering key client relationships. With a strong enterprise mindset, Corona has focused her career on serving large, global clients and brings a holistic and integrated view to how the firm delivers more for its clients while identifying, onboarding, training and developing opportunities for client-facing talent. She will continue to be a member of the Aon Executive Committee and to report to Goltermann.

“I am honored to assume this global responsibility and work more closely with our talented team of leaders to support our clients around the world”, said Corona. “Aon’s commitment to innovation is creating key points of difference in how we serve our clients across Risk Capital and Human Capital and delivering unmatched content, capability and expertise to our clients.”
Hashtag: #Aon

The issuer is solely responsible for the content of this announcement.

About Aon

(NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.

Follow Aon on , , and . Stay up-to-date by visiting Aon’s and sign up for news alerts .

Disclaimer
The information contained in this document is solely for information purposes, for general guidance only and is not intended to address the circumstances of any particular individual or entity. Although Aon endeavours to provide accurate and timely information and uses sources that it considers reliable, the firm does not warrant, represent or guarantee the accuracy, adequacy, completeness or fitness for any purpose of any content of this document and can accept no liability for any loss incurred in any way by any person who may rely on it. There can be no guarantee that the information contained in this document will remain accurate as on the date it is received or that it will continue to be accurate in the future. No individual or entity should make decisions or act based solely on the information contained herein without appropriate professional advice and targeted research.

Gorilla Technology Group Adds Tech Luminary Thomas Sennhauser to Board of Directors


London, United Kingdom – Newsfile Corp. – December 2, 2024 – Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), proudly announces the appointment of Thomas Sennhauser to its esteemed Board of Directors, effective 1st December 2024.

With a stellar career spanning over two decades, Thomas brings unparalleled expertise in technology leadership, R&D and digital transformation. Currently serving as the CTO and Business Lead, APJ, at Intel Corporation, he has driven ground-breaking advancements in AI, IoT, SDN and Cloud Infrastructure, forging partnerships that have reshaped industries across the Asia-Pacific region and beyond.

“Thomas’s appointment signals a new era for Gorilla,” said Jay Chandan, Chairman and CEO of Gorilla Technology. “His visionary leadership and deep technical expertise align perfectly with our ambitious goals. With Thomas on board, we are poised to elevate Gorilla’s innovation and global influence to unprecedented heights.”

Thomas Sennhauser, Board Member

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10783/232132_f1a00128b4f5a9b8_001full.jpg

Thomas’s career is a testament to strategic brilliance and technical mastery. At Intel, he has spearheaded initiatives that delivered transformative solutions, from building advanced cloud ecosystems to enabling AI-powered business outcomes. Prior to Intel, his roles at Hewlett Packard Enterprise further solidified his reputation as a global technology strategist, particularly in emerging fields like Network Function Virtualisation (NFV) and Software Defined Networking (SDN).

“Joining Gorilla’s Board of Directors is an honour,” said Thomas Sennhauser. “Gorilla’s commitment to driving innovation and solving the challenges of tomorrow resonates deeply with me. I look forward to collaborating with the team to achieve bold, transformational milestones.”

Thomas will contribute to the strategic direction and governance of Gorilla as it scales its operations, strengthens its market leadership and continues its mission to redefine industries through cutting-edge AI, cybersecurity and smart city solutions.

This appointment comes at a time of significant momentum for Gorilla, as the company expands its global footprint and deepens its impact across sectors ranging from public safety to enterprise efficiency.

About Gorilla Technology Group Inc.

Headquartered in London U.K., Gorilla is a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology. We provide a wide range of solutions, including, Smart City, Network, Video, Security Convergence and IoT, across select verticals of Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare and Education, by using AI and Deep Learning Technologies.

Our expertise lies in revolutionizing urban operations, bolstering security and enhancing resilience. We deliver pioneering products that harness the power of AI in intelligent video surveillance, facial recognition, license plate recognition, edge computing, post-event analytics and advanced cybersecurity technologies. By integrating these AI-driven technologies, we empower Smart Cities to enhance efficiency, safety and cybersecurity measures, ultimately improving the quality of life for residents.

For more information, please visit our website: Gorilla-Technology.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are based on estimates, assumptions, and expectations. Actual results and performance could differ materially and adversely from those expressed or implied in forward-looking statements. Gorilla does not undertake any obligation to update any forward-looking statements, except as required by law.

Investor Relations Contact:
Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
GRRR@redchip.com

The issuer is solely responsible for the content of this announcement.

About Gorilla Technology Group Inc.

First Phosphate Corp. Signs License Agreement with Prayon SA, Global Leader in MGA Phosphoric Acid Technology


Saguenay, Quebec – Newsfile Corp. – December 2, 2024 – First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company”) is pleased to announce that it has signed a technology license agreement (“TLA”) with Prayon SA of Engis, Belgium (“Prayon”) for the technology to produce merchant grade phosphoric acid (MGA) from igneous apatite phosphate rock as well as high-purity gypsum.

Prayon will grant First Phosphate a license to use its technology to design, build, operate and maintain, within Canada, a Merchant Grade phosphoric acid (MGA) manufacturing plant with a production capacity of six hundred (600) metric tons of product per day of P2O5 (phosphate).

Further, First Phosphate has also selected Ballestra S.pA. of Milan, Italy (“Ballestra”) from a group of official permanent licensees of Prayon to fulfill the service agreement (“SA”) for the engineering services portion (FEED and EPC/EPCM) for the project.

Lastly, First Phosphate’s relationship with Norfalco, a division of Glencore Canada, (“Norfalco-Glencore”) dated July 2023, remains in place for secure supply of sulfuric acid for this future phosphoric acid facility.

“With these technology, engineering and sulfuric acid supply agreements in place, First Phosphate will have the ability to implement a process to convert approximately 500,000 tonnes per annum of igneous apatite originating from its future mining operations into upwards of 190,000 annual tonnes of value-added phosphoric acid,” says Company CEO, John Passalacqua.

“Through the sale of this license, Prayon gives First Phosphate access to a world-renowned technology and highlights its commitment to transforming a critical, strategic material into high-value-added products, while recycling by-products in a well-established circular economy,” says Benoît Van Massenhove of Prayon SA.

About First Phosphate Corp.

First Phosphate is a mineral development company fully dedicated to extracting and purifying phosphate for the production of cathode active material for the Lithium Iron Phosphate (“LFP”) battery industry. First Phosphate is committed to producing at high purity level, at full ESG standard and with low anticipated carbon footprint. First Phosphate plans to vertically integrate from mine source directly into the supply chains of major North American LFP battery producers that require battery grade LFP cathode active material emanating from a consistent and secure supply source. First Phosphate is owner and developer of the Bégin-Lamarche property in Saguenay-Lac-St-Jean, Quebec, Canada that consists of rare anorthosite igneous phosphate rock that generally yields high purity phosphate material devoid of high concentrations of harmful elements.

About Prayon SA

Headquartered in Belgium, Prayon is a world-leading phosphate research, development and production company. Prayon has 1,400 employees and over 140 years of business experience. The Prayon Group has production sites in Belgium, France, Switzerland and the United States, research and development sites in Belgium and a testing and validation facility in Bulgaria (Technophos). OCP and Wallonie Entreprendre (WE) are Prayon’s two shareholders. OCP is the Moroccan state-owned phosphate rock miner, phosphoric acid manufacturer and fertilizer producer. OCP operations span five continents throughout the value chain, from mining and manufacturing to education and community development. WE is a public sector private-equity group that aims to accelerate the growth and transformation of Walloon businesses for the benefit of economic development and employment in Wallonia, Belgium.

About Ballestra Group

Ballestra S.p.A. is an international technology-oriented contractor based in Milano (Italy), with subsidiaries in Pratteln (Switzerland), and Bangalore (India) and over 450 employees worldwide. Ballestra is a permanent licensee of Prayon Technologies handling all process configurations and having delivered 13 projects to date successfully. Since 1960, Ballestra has performed hundreds of process plant EP or EPC projects and has access to a worldwide network of construction partners that allows a high level of construction servicing in any country.

For additional information, please contact:

Bennett Kurtz
Chief Financial Officer
bennett@firstphosphate.com
Tel: +1 (416) 200-0657

Investor Relations: investor@firstphosphate.com
Media Relations: media@firstphosphate.com
Website: www.FirstPhosphate.com

Follow First Phosphate:
Twitter: https://twitter.com/FirstPhosphate
LinkedIn: https://www.linkedin.com/company/first-phosphate/

Forward-Looking Information and Cautionary Statements

This news release contains certain statements and information that may be considered “forward-looking statements” and “forward looking information” within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking statements and forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved” and other similar expressions. In addition, statements in this news release that are not historical facts are forward looking statements, including, among other things, the Company’s planned exploration and production activities, the properties and composition of any extracted phosphate, the Company’s plans for vertical integration into North American supply chains, and the design, build, operation and maintenance, within Canada, of a phosphoric acid manufacturing plant with a production capacity of six hundred metric tons of product per day of P2O5.

These statements and other forward-looking information are based on assumptions and estimates that the Company believes are appropriate and reasonable in the circumstances, including, without limitation, expectations of the Company’s long term business outcomes given its short operating history; expectations regarding revenue, expenses and operations; the Company having sufficient working capital and ability to secure additional funding necessary for the exploration of the Company’s property interests; expectations regarding the potential mineralization, geological merit and economic feasibility of the Company’s projects; expectations regarding drill programs and the potential impacts successful drill programs could have on the life of the mine and the Company; mineral exploration and exploration program cost estimates; expectations regarding any environmental issues that may affect planned or future exploration programs and the potential impact of complying with existing and proposed environmental laws and regulations; receipt and timing of exploration and exploitation permits and other third-party approvals; government regulation of mineral exploration and development operations; expectations regarding any social or local community issues that may affect planned or future exploration and development programs; expectations surrounding global economic trends and technological advancements; key personnel continuing their employment with the Company; having sufficient working capital and ability to secure additional funding necessary to design, build, operate and maintain a phosphoric acid manufacturing plant, and receipt and timing of all permits and third-party approvals.

There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include: limited operating history; high risk of business failure; no profits or significant revenues; limited resources; negative cash flow from operations and dependence on third-party financing; the uncertainty of additional funding; no dividends; risks related to possible fluctuations in revenues and results; insurance and uninsured risks; litigation; reliance on management and key personnel; conflicts of interest; access to supplies and materials; dangers of mineral exploration and related liability and damages; risks relating to health and safety; government regulation and legal uncertainties; the company’s exploration and development properties may not be successful and are highly speculative in nature; dependence on outside parties; title to some of the Company’s mineral properties may be challenged or defective; Aboriginal title and land claims; obtaining and renewing licenses and permits; environmental and other regulatory risks may adversely affect the company; risks relating to climate change; risks related to infrastructure; land reclamation requirements may be burdensome; current global financial conditions; fluctuation in commodity prices; dilution; future sales by existing shareholders could cause the Company’s share price to fall; fluctuation and volatility in stock exchange prices; and risks related to market demands. There can be no assurance that any opportunity will be successful, commercially viable, completed on time or on budget, or will generate any meaningful revenues, savings or earnings, as the case may be, for the Company. In addition, the Company will incur costs in pursuing any particular opportunity, which may be significant.

These factors and assumptions are not intended to represent a complete list of the factors and assumptions that could affect the Company and, though they should be considered carefully, should be considered in conjunction with the risk factors described in the Company’s other documents filed with the Canadian and United States securities authorities, including without limitation the “Risk Factors” section of the Company’s Management Discussion and Analysis dated October 23, 2024 and Annual Report on 20-F dated July 8, 2024, which are available on SEDAR at www.sedarplus.ca. Although the Company has attempted to identify factors that would cause actual actions, events or results to differ materially from those disclosed in the forward-looking information or information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

The issuer is solely responsible for the content of this announcement.

About First Phosphate Corp.

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s Syndrome Drug


San Diego, California – Newsfile Corp. – December 2, 2024 – Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) (“Ainos” or the “Company”), an innovative healthcare company focused on advanced AI-driven point-of-care testing (“POCT”) and low-dose interferon therapeutics, today proudly announced the signing of a strategically significant Memorandum of Understanding (MOU) with Taiwan Tanabe Seiyaku Co., Ltd., a subsidiary of Mitsubishi Tanabe Pharma Corporation in Japan, brings extensive pharmaceutical development and manufacturing expertise to the partnership. The collaboration aims to advance the manufacturing and Taiwan market promotion of Ainos’ groundbreaking Sjögren’s syndrome drug, VELDONA®. Both parties may work under the terms of the MOU to further define the partnership.

Market Demand for Sjögren’s Syndrome Treatment

Sjögren’s syndrome is an autoimmune disease affecting millions of patients worldwide, with a significant unmet need for effective treatments. As the global population ages and awareness of the disease increases, the demand for therapeutic solutions is growing rapidly. According to market analysis, the global Sjögren’s syndrome market is projected to reach billions of dollars in the next five years. Ainos believes VELDONA® will provide a much-needed, innovative treatment option for millions of patients and fulfill this pressing market demand.

VELDONA®‘s Clinical Progress and Success

Ainos has dedicated years to the development of Sjögren’s syndrome treatments, with VELDONA®, a low-dose oral interferon-alpha, showing remarkable potential in clinical trials. Previous studies have demonstrated that VELDONA® can significantly alleviate patient symptoms, improve quality of life, and effectively control disease progression. The drug has shown strong tolerability and safety, establishing a solid foundation for further large-scale global clinical trials.

Partnership with Taiwan Tanabe Seiyaku

Taiwan Tanabe Seiyaku, as a subsidiary of Mitsubishi Tanabe Pharma, offers extensive experience in pharmaceutical development and market expansion. As part of this partnership, Taiwan Tanabe Seiyaku may collaborate with Ainos on the manufacturing and promotion of VELDONA® to meet market demand. Both parties will clarify the specific details and responsibilities of the partnership as stipulated in the MOU agreement.

Global Market Impact and Future Outlook

This collaboration with Taiwan Tanabe Seiyaku will accelerate the global market introduction of VELDONA®, ensuring that the drug reaches patients in a timely and efficient manner. The formal contract will define the clear rights and responsibilities of both parties, paving the way for long-term success. Ainos anticipates that as more clinical data is collected and the drug becomes available in more markets, the demand for VELDONA® will solidify its position as a leading treatment for Sjögren’s syndrome. Additionally, the success of this drug will open further opportunities in other autoimmune diseases, enhancing the company’s market valuation and growth potential.

Ainos’ Future Vision

Ainos is committed to driving medical innovation and addressing the world’s unmet medical needs. This partnership with Taiwan Tanabe Seiyaku marks an important milestone in our global strategy, and we will continue to focus on developing breakthrough therapies that improve the quality of life for patients worldwide.

About Ainos, Inc.

Headquartered in San Diego, California, Ainos is a diversified healthcare company focused on novel AI-powered point-of-care testing (POCT) and low-dose interferon therapeutics (VELDONA®). The Company’s clinical-stage product pipeline includes VELDONA® human and animal oral therapeutics, human orphan drugs, and telehealth-friendly POCT solutions powered by its AI Nose technology platform. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

About Taiwan Tanabe Seiyaku Co., Ltd.

Taiwan Tanabe Seiyaku Co., Ltd., a subsidiary of Mitsubishi Tanabe Pharma Corporation, was established in 1962. The company is focused on providing high-quality pharmaceutical products and innovative therapeutic solutions in Taiwan and neighboring markets, covering key therapeutic areas such as autoimmune diseases, diabetes, and other major health conditions.

Safe Harbor Statement

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-Looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “approximate,” “expect,” “intend,” “plan,” “predict,” “project,” “target,” “future,” “likely,” “strategy,” “foresee,” “may,” “guidance,” “potential,” “outlook,” “forecast,” “should,” “will” or other similar words or phrases. Similarly, statements that describe the Company’s objectives, plans or goals are, or may be, forward-looking statements. Forward-Looking statements are based only on the Company’s current beliefs, expectations, and assumptions. Forward-Looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results may differ materially from those indicated in the forward-looking statements.

Important factors that could cause the Company’s actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release include, among others, the cost of production and sales potential of the products announced in this press release; the Company’s dependence on projected revenues from the sale of current or future products; the Company’s limited cash and history of losses; the Company’s ability to achieve profitability; the Company’s ability to raise additional capital to continue the Company’s product development; the ability to accurately predict the future operating results of the Company; the ability to advance Ainos’ current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates the Company develops; the ability to obtain and maintain regulatory approval of Ainos’ product candidates; delays in completing the development and commercialization of the Company’s current and future product candidates, which could result in increased costs to the Company, delay or limit the ability to generate revenue and adversely affect the business, financial condition, results of operations and prospects of the Company; intense competition and rapidly advancing technology in the Company’s industry that may outpace its technology; customer demand for the products and services the Company develops; the accuracy of third-party market research data, the impact of competitive or alternative products, technologies and pricing; disruption in research and development facilities; lawsuits and other claims by third parties or investigations by various regulatory agencies governing the Company’s operations; potential cybersecurity attacks; increased requirements and costs related to cybersecurity; the Company’s ability to realize the benefits of third party licensing agreements; the Company’s ability to obtain and maintain intellectual property protection for Ainos product candidates; compliance with applicable laws, regulations and tariffs; continued listing on and compliance with the applicable regulations of the Nasdaq Capital Market; and the Company’s success in managing growth. A more complete description of these risk factors and others is included in the “Risk Factors” section of Ainos’ Annual Report on Form 10-K for the year ended December 31, 2023, and other public filings with the U.S. Securities and Exchange Commission (“SEC”), many of which risks are beyond the Company’s control. In addition to the risks described above and in the Company’s filings with the SEC, other unknown or unpredictable factors also could cause actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release.

The forward-looking statements made in this press release are expressly qualified in their entirety by the foregoing cautionary statements. Any forward-looking statements contained in this press release represent Ainos’ views only as of today and should not be relied upon as representing its views as of any subsequent date. Ainos undertakes no obligation to, and expressly disclaims any such obligation to, publicly update or revise any forward-looking statement to reflect changed assumptions, the occurrence of anticipated or unanticipated events or changes to the future results over time or otherwise, except as required by law.

Contact Information
Feifei Shen
ir@ainos.com

The issuer is solely responsible for the content of this announcement.

About Ainos, Inc.

LOVE DIVING: DOT launches Philippine Dive Experience in Anilao, Batangas


ANILAO, BATANGAS, PHILIPPINES – Media OutReach Newswire – 2 December 2024 – The Philippine Department of Tourism (DOT) officially launched the first Philippine Dive Experience on Thursday (November 27) to reinforce the country’s position as a premier global destination for diving and marine biodiversity exploration.

Tourism Secretary Christina Garcia Frasco joins delegates of the Department of Tourism’s inaugural Philippine Dive Experience at LOVE Reef—an artificial structure designed to support coral growth, provide habitat and breeding grounds for marine species, and enhance shoreline protection. Photo by the Philippine Department of Tourism.
Tourism Secretary Christina Garcia Frasco joins delegates of the Department of Tourism’s inaugural Philippine Dive Experience at LOVE Reef—an artificial structure designed to support coral growth, provide habitat and breeding grounds for marine species, and enhance shoreline protection. Photo by the Philippine Department of Tourism.

Highlighting the Philippines’ recognition as the World’s Leading Dive Destination for the sixth consecutive year at the World Travel Awards, Tourism Secretary Christina Garcia Frasco led the dive-focused initiative under the DOT’s Philippine Experience program which brought together high-ranking diplomats including South Korean Ambassador to the Philippines H.E. Lee Sang Hwa, Bangladesh Ambassador H.E F.M Borhan Uddin, Indian Ambassador H.E. Harsh Kumar Jain, Lao-PDR Ambassador H.E. Sonexay Vannaxay, Malaysian Ambassador H.E. Malik Melvin, New Zealand Ambassador H.E. Catherine McIntosh, Sri Lanka Ambassador H.E Chanaka Talpahewa, Thailand Ambassador H.E. Tull Traisorat, Vietnam Ambassador H.E. Lai Binh, as well as diplomatic and consular corps from Cambodia, China, France, Indonesia, and the United States of America.

They were joined by leaders in the dive and tourism sectors, heads of tourism associations, dive operators, and certification agencies at the gathering, which celebrated the Philippines’ unparalleled marine biodiversity and its potential to attract global attention.

In her keynote address, Secretary Frasco underscored the event’s alignment with President Ferdinand Marcos, Jr.’s vision for tourism transformation. “At the heart of the Philippine Dive Experience is our President’s vision of transformation for tourism. We’re not interested in recovering only what was lost, but rather in transcending to the rightful place that the Philippines deserves in the global community of tourism nations. A country that prioritizes the sustainability of its destination and the regeneration of its resources while it seeks to reintroduce itself to the world from the strength of its identity, heritage, and culture.”

Anilao: A Gateway to Global Dive Tourism

Anilao, a world-renowned diving destination, was the launch point for the Philippine Dive Experience tourism circuit. Secretary Frasco highlighted Anilao’s strategic role and its connection to the globally significant Verde Island Passage. “Starting here in Anilao, Batangas, a world-renowned diving destination, we shine a spotlight on the Verde Island Passage. This globally significant corridor is a haven for marine life and a dream destination for underwater photographers.”

Certified divers explored Anilao’s vibrant underwater landscapes, including the LOVE Reef—an artificial reef created through community-driven conservation efforts. Non-divers were introduced to the underwater world through guided scuba experiences, offering an immersive glimpse into the Philippines’ marine treasures.

A coastal cleanup at Anilao Pier emphasized the DOT’s commitment to sustainable tourism. Secretary Frasco remarked. “On the sustainability of dive tourism, we have worked with our partners both from the private sector, our regional offices, and our stakeholders from around the world to continue interest for Philippine diving, as well as to inject education and importance on the conservation of our marine resources.”

Enhancing Dive Tourism Infrastructure and Training

During the event, Secretary Frasco announced key initiatives to boost dive tourism, including the installation of hyperbaric chambers at strategic dive sites to ensure diver safety and meet international standards. She also highlighted the success of the Filipino Brand of Service Excellence (FBSE) program, which has trained over 262,000 tourism professionals nationwide, including more than 10,000 from the CALABARZON region.

These efforts come as the Philippine dive industry continues to thrive, contributing ₱73 billion in revenue in 2023 and playing a crucial role in sustainable economic growth, livelihood creation, and environmental conservation.

“To our esteemed friends from the diplomatic community, our partners, all the delegates and participants, we invite you to become ambassadors for Philippine diving. Together, we will share to the world the beauty of our dive destinations and to ensure the treasures of our seas remain a source of pride and prosperity for generations to come,” Secretary Frasco said, urging attendees to champion the country’s underwater wonders.

Recognition for the Philippine Dive Industry

The DOT celebrated a banner year for Philippine diving, earning the title of World’s Leading Dive Destination for the sixth consecutive year at the World Travel Awards. The country also received accolades such as Best Dive Destination at the TripZilla Excellence Awards and Best Diving Destination at the Diving Resort Travel Show.

Batangas Governor Hermilando Mandanas, represented by Provincial Administrator Wilfredo Celis, welcomed the Philippine Dive Experience delegates. “Batangas is very pleased to be a host to all of you in the next two days. I’m sure you will find your experience as pleasant as possible. And again, we’d like to thank the Department of Tourism for its continued support to the province.”

Mabini Mayor Nilo Villanueva, through Tourism Officer Ian Bueno, expressed gratitude for hosting the inaugural Philippine Dive Experience. “Our community takes pride in our natural treasures, and we are excited to share them with you. This event is not just about exploring the depths of our oceans, but also about fostering international cooperation and promoting sustainable tourism.”

A Sustainable and Immersive Dive Experience

The second day of the Philippine Dive Experience will feature a coastal cleanup at Anilao Pier, with participants—including members of the diplomatic corps and local volunteers—working together to protect marine environments. This will be followed by a cultural immersion via the Taal Heritage Tour, highlighting Batangas’ rich history and artistry, and offering visitors a deeper appreciation of the province’s vibrant cultural identity.

Hashtag: #DOT

The issuer is solely responsible for the content of this announcement.

Rediscovering the North Coast—Exploring Aesthetic Destinations and Experiencing the Beauty of Taiwan


TAIPEI, TAIWAN – Media OutReach Newswire – 2 December 2024 – The scenic splendor and unique charm of Taiwan’s North Coast have long captivated the hearts of countless artists, serving as a wellspring of creative inspiration. Today, the North Coast and Guanyinshan National Scenic Area Headquarters, Tourism Administration, MOTC collaborates with renowned artists, seamlessly blending art into natural landscapes. This project introduces new aesthetic “Instagram-worthy” destinations, inviting travelers to not only revel in breathtaking scenery but also engage with art on a deeply personal level.

Walking map of the 12 artistic attractions, including bike-friendly sightseeing routes, to guide visitors deeper into the landscape and discover the wonders waiting within.
Walking map of the 12 artistic attractions, including bike-friendly sightseeing routes, to guide visitors deeper into the landscape and discover the wonders waiting within.

The concept for this project draws inspiration from iconic works by European and American artists. These pieces not only record the natural beauty of their surroundings but have also become landmarks in their own right, attracting visitors from near and far. Through the power of social media, these art installations reveal the enchanting harmony between Taiwan’s natural landscapes and artistic expression, opening a window to the island’s beauty for travelers worldwide.

For this project, six prominent Taiwanese contemporary artists were invited: Chao Kuo-Tsung (Zao Bi), former director at Taipei National University of the Arts (TNUA); Ko Hung-Tu, former chairman of the Graphic Design Association of the Republic of China; Lin Chang-Hu, former dean of the TNUA School of Fine Arts; Lee Cheng-Ming, vice president of the Taiwan Academy of Fine Arts; Apex Lin Pang-Soong, recipient of a 2007 National Award for Arts in the fine arts category; and Chuang Lien-Tung, professor in the Department of Fine Arts and dean of the College of Arts at National Taiwan Normal University. Their works, integrated into iconic locations along the North Coast, reflect nature’s beauty through a variety of media and leave a lasting aesthetic imprint on the landscape. Inspired by the way Western artists have created selfie-worthy destinations, these North Coast installations create Instagrammable art locations that encourage visitors to explore, take photos, and experience the beauty of the scenery from the artists’ unique perspectives. With the combined power of art and social media, these destinations not only enrich visitors’ experiences but also promote the North Coast’s diverse attractions to a wider audience.

The designated destinations include stunning sites such as Heping Island Geopark, Yehliu Geopark, Shimen (Stone) Arch, Shitoushan Park—Twin Candlestick Islets, Laomei Green Reef (Stone Troughs), Fugui Cape Lighthouse, and Guanyinshan. Each location offers a unique artistic view, inviting visitors to not only admire the natural beauty but also immerse themselves in the magic of artistic expression.

These aesthetic destinations transform landscapes into approachable art pieces, and encourage visitors to take geo-tagged photos and post them on social media to introduce the beauty of the North Coast to more people. For both art enthusiasts and travelers seeking inspiration, these stops are destined to become must-visit destinations for those exploring Taiwan.

When you have the time, take a leisurely trip to Northern Taiwan and uncover these aesthetic attractions along the North Coast. Experience the seamless blend of nature and art, and bring this beauty into your heart to accompany you on life’s journey.
Hashtag: #NorthCoastandGuanyinshanNationalScenicArea

The issuer is solely responsible for the content of this announcement.

MIPIM Asia Summit 2024: Asia’s Leading Platform for Real Estate Investment and Partnerships


HONG KONG SAR – Media OutReach Newswire – 2 December 2024 – The 18th MIPIM Asia Summit returns this year to address key themes reshaping the real estate landscape in Asia and globally. Bringing together prominent international investors and speakers, the MIPIM Asia Summit 2024 will feature the prestigious MIPIM Asia Awards Ceremony and take place on December 3rd and 4th at the Grand Hyatt in Hong Kong. Since its inception, Hong Kong has hosted the MIPIM Asia Summit, which has continuously evolved into the most reputable real estate investment gathering in the region.

Amidst a backdrop of cautious optimism in Asian real estate, this year’s summit will focus on envisioning the future of Asian property markets with an emphasis on durability and digital transformation, seeking long-term economic growth, sustainable practices, and community cohesion. Ultimately, the evolving landscape presents a promising frontier for collaboration and investment that can shape the region’s future.

With interest rates in major markets either expected to decline or already decreasing, many investors are finding real assets increasingly attractive. Optimism is growing that debt conditions will become more favourable for transactions, driving up deal volumes and centering key discussions on debt, digitalisation, and decarbonisation. This highlights a significant shift in investment dynamics across the region.

MIPIM Asia is the premier platform for industry leaders to drive transformative discussions during pivotal times for our global communities. We’re honoured to welcome delegates from around the world, including Georgia and the Middle East, and are especially proud to host Baroness Poppy Gustafsson OBE, Minister for Investment at the UK Department for Business & Trade. From MIPIM Asia in Hong Kong to MIPIM in Cannes, our events offer unparalleled access to global capital and actionable solutions to make assets more sustainable in an ever-changing world.” commented Nicolas Kozubek, Head of MIPIM Markets.

The MIPIM Asia Summit 2024 will feature 60+ speakers and 300+ participants, including notable dynamic real estate investors, listed below in alphabetical order by company name:

  • Pak Man Yuen, Managing Director of Blackstone
  • Beverley Churchill, CEO of Churchill & Partners
  • Justin Chiu, Executive Director of CK Asset Holdings Limited
  • Rebecca Lam, Managing Director of Cppi
  • Kenneth Yeung, Managing Director, Regional Head of Real Estate, Asia ex Japan – Credit Agricole Corporate & Investment Bank
  • Sherman Hung, Managing Director, Head of Large Corporate of DBS Bank Ltd
  • Christina Gaw, Managing Principal, Global Head of Capital Markets and Co-Chair of Alternative Investments of Gaw Capital Partners
  • Phillip Wong, Head of Private Markets of the Hong Kong Monetary Authority
  • John Pattar, Partner and Head of Asia Real Estate of KKR Asia Limited
  • George Hongchoy, Executive Director and Group CEO of Link Asset Management Limited
  • Carl Schibrowski, Chief Development Officer of New Murabba
  • Wei Yao, Chief Economist, APAC of Société Générale
  • Shelley Boland, Global Head, Corporate Real Estate and Services of Standard Chartered
  • Baroness Poppy Gustafsson OBE, Minister for Investment at UK Department for Business & Trade

This year’s MIPIM Asia Summit will gather C-suite executives and top leaders from over 20 countries, alongside renowned global investors. Key participants include prominent names such as APG, BEI Group, Caisse de Depot, Champion REIT, Chinachem Group, Employees Provident Fund, GIC Real Estate, Hong Kong Monetary Authority, Mapletree, Nan Fung Group, PAG, Ping An Insurance, PIMCO PRIME Real Estate GMBH, Qatar Investment Authority, Quadreal, and Townsend Group. The event will also feature a variety of end-user and retail representatives from global brands such as Victorinox, TUMI, Apple, Furla, Ralph Lauren, and Pfizer, making the Summit a premier platform for high-level networking and investment opportunities.

As a cornerstone of the Asia Pacific real estate calendar, the MIPIM Asia Summit continues to attract influential decision-makers and showcase the region’s most cutting-edge projects, solidifying its position as a leading platform for the property industry.

For more information about MIPIM Asia Awards 2024 Winners, please visit HERE.

For more information about the Summit and Awards, please visit mipim-asia.com.

For instant updates, please follow MIPIM: Facebook Twitter LinkedIn

Hashtag: #MIPIM

The issuer is solely responsible for the content of this announcement.

MIPIM Asia Summit

MIPIM Asia Summit is the annual property leaders’ summit in Asia Pacific organised by RX France. It is the major gathering where top-level decision makers gather to explore new business partnerships and investment opportunities. It features expert-led conference sessions, premium networking accelerators and an exclusive awards gala dinner over a two-day period. Distinguished speakers, senior executives, high-level business professionals and industry experts from around the world will discuss the latest developments and prevailing trends in the property and retail industry. MIPIM – the world’s property market – is the leading and largest global property event. The four-day event takes place annually in Cannes every March. 22,500+ delegates attended in 2023 with over 2,000 Investment & Financial companies, and more than 90 different countries being represented.

RX

is a global leader in events and exhibitions, leveraging industry expertise, data, and technology to build businesses for individuals, communities, and organisations. With a presence in 25 countries across 42 industry sectors, RX hosts approximately 350 events annually. is committed to creating an inclusive work environment for all our people. RX empowers businesses to thrive by leveraging data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit .

creates high level, world-class and market leader meeting places, covering 15 industry sectors, including MIPIM, MAPIC, Batimat, Pollutec, EquipHotel, SITL, IFTM, Big Data & AI Paris, MIPCOM, Paris Photo, Maison&Objet*… and many more. RX France’s events take place in France, Hong Kong, Italy and Mexico. For more information, visit

*Organised by Safi, a subsidiary of RX France and Ateliers d’Art de France

RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. RELX serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 36,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

*Note: Current market capitalisation can be found at

Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market


HONG KONG SAR – EQS Newswire – 2 December 2024 – Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce two significant milestones that demonstrate the Group’s continued growth and innovation in the field of medical aesthetics and dermatological solutions.

Group photo of the launch of 肌顏態®
Group photo of the launch of 肌顏態®

The Group’s strategic cooperation product with Chongqing Minji Medical Device Co., Ltd., recombinant collagen dressing, has successfully received Class II medical device approval, with the approval number “渝械注准 20242140377”. At the same time, the Group’s self-developed medical aesthetics product, 肌顏態®, was successfully launched, marked by a grand event held in Wuhan. The launch brought together industry experts, key opinion leaders, media representatives, and other professionals to witness the Group’s entry into the rapidly growing medical aesthetics market, valued at hundreds of billions of RMB. This milestone signifies a bold new chapter for the Group as it continues to expand its presence in this high-potential sector.

Collagen, which is central to the newly approved recombinant collagen dressing, is the most abundant protein in the human body, comprising 25–35% of total protein content. It forms a network of elastic fibers that support the skin’s structure, maintain elasticity, and lock in moisture. However, collagen production decreases by approximately 1% annually after maturity (around age 21), leading to a loss of skin firmness and elasticity. Collagen-based products have a wide range of applications, including moisturizing, maintaining the skin barrier, and addressing signs of aging. In addition to dressing, microneedles for collagen are also being developed.

The launch of 肌顏態®, developed based on proprietary patents of Skbrella™ FN (Recombinant Human Fibronectin), marks another key milestone in the Group’s efforts to expand its portfolio. 肌顏態® is designed to provide safe, effective solutions for improving skin quality and repair, making it ideal for treating damaged skin, acne-prone skin, and for post-medical procedure care. Fibronectin, a multifunctional extracellular matrix glycoprotein, plays a vital role in cell migration, adhesion, proliferation, hemostasis, and tissue repair. It is worth mentioning that the Group is advancing the development of its fibronectin-based medical device.

Photo left:肌顏態® Fibronectin Repair Solution; Photo right:肌顏態® Fibronectin Serum
Photo left:肌顏態® Fibronectin Repair Solution; Photo right:肌顏態® Fibronectin Serum

The debut of肌顏態® has attracted high recognition and attention from many dermatologists and medical aesthetics practitioners. At the launch, experts and scholars conducted professional academic exchanges and case sharing on the effects and clinical use of fibronectin from different perspectives “肌顏態®, a product designed for use throughout the entire cycle of preoperative and post-medical procedures, demonstrates significant effectiveness, particularly for patients with anesthetic allergies. It enables rapid skin repair and reduces redness efficiently.”

Dermatology clinical practice sharing by Professor Yang Bin, President of Guangdong Dermatology Hospital, Southern Medical University
Dermatology clinical practice sharing by Professor Yang Bin, President of Guangdong Dermatology Hospital, Southern Medical University
肌顏態® use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University
肌顏態® use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University

Mr. Frank Zhao, CEO of Uni-Bio Science Group, also said: “The Group will leverage its professional expertise in dermatology, nearly three decades robust clinical data from GeneTime , and its established sales network, adhering to the rigorous R&D standards of pharmaceutical companies, to build a diversified product portfolio across biological drugs, medical devices, and medical aesthetics, ultimately providing safer and more effective full-cycle skincare solutions for patients.”

Photo left: Mr. Frank Zhao, CEO of Uni-Bio Science Group delivered opening speech for the launch of 肌顏態®; Photo right: Dr. Yu Shan, Deputy Director of R&D and Project of Uni-Bio Science Group, introduction of 肌顏態®
Photo left: Mr. Frank Zhao, CEO of Uni-Bio Science Group delivered opening speech for the launch of 肌顏態®; Photo right: Dr. Yu Shan, Deputy Director of R&D and Project of Uni-Bio Science Group, introduction of 肌顏態®

The Group is well-positioned to capitalize on the growing opportunities in the market. Industry forecasts indicate that the medical aesthetic market is set to sustain a CAGR growth of 10% to 15% between 2024 and 2027, and is expected to exceed RMB 600 billion in 2030. The approval of collagen medical devices and the launch of 肌顏態® herald a new journey for the Group in the field of skin care.

Mr. Kingsley Leung, Chairman of Uni-Bio Science Group, success entered in partnerships with various renowned medical aesthetics clinic chain and distributors
Mr. Kingsley Leung, Chairman of Uni-Bio Science Group, success entered in partnerships with various renowned medical aesthetics clinic chain and distributors

These achievements reflect the Group’s strong commitment to innovation, strategic execution, and value creation. As the Group continues to execute its strategic vision, it remains focused on its goal of becoming China’s leading expert in dermatology, leveraging innovation, clinical expertise, and market insight to drive sustainable growth and long-term success.

Hashtag: #Uni-BioScience

The issuer is solely responsible for the content of this announcement.